
Lifecore Biomedical, Inc.
NASDAQ:LFCR
6.38 (USD) • At close April 25, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Lifecore Biomedical, Inc. |
Symbool | LFCR |
Munteenheid | USD |
Prijs | 6.38 |
Beurswaarde | 236,221,414 |
Dividendpercentage | 0% |
52-weken bereik | 3.68 - 7.99 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. James G. Hall |
Website | https://www.lifecore.com |
An error occurred while fetching data.
Over Lifecore Biomedical, Inc.
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)